Liu YY - Search Results

1

Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors.

Liu YY. Liu YY. Cancer Res. 2011 Oct 15;71(20):6295-9. doi: 10.1158/0008-5472.CAN-11-0700. Epub 2011 Oct 4. Cancer Res. 2011. PMID: 21972148 Free PMC article. Review.

2

Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.

Liu YY, Patwardhan GA, Bhinge K, Gupta V, Gu X, Jazwinski SM. Liu YY, et al. Cancer Res. 2011 Mar 15;71(6):2276-85. doi: 10.1158/0008-5472.CAN-10-3107. Epub 2011 Jan 28. Cancer Res. 2011. PMID: 21278235 Free PMC article.

3

Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.

Liu YY, Hill RA, Li YT. Liu YY, et al. Adv Cancer Res. 2013;117:59-89. doi: 10.1016/B978-0-12-394274-6.00003-0. Adv Cancer Res. 2013. PMID: 23290777 Free PMC article. Review.

4

Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Khiste SK, Liu Z, Roy KR, Uddin MB, Hosain SB, Gu X, Nazzal S, Hill RA, Liu YY. Khiste SK, et al. Among authors: liu yy, liu z. Mol Cancer Ther. 2020 Feb;19(2):564-574. doi: 10.1158/1535-7163.MCT-19-0366. Epub 2019 Oct 23. Mol Cancer Ther. 2020. PMID: 31645443 Free PMC article.

5

Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.

Gupta V, Patwardhan GA, Zhang QJ, Cabot MC, Jazwinski SM, Liu YY. Gupta V, et al. Among authors: liu yy. J Lipid Res. 2010 Apr;51(4):866-74. doi: 10.1194/jlr.D002949. Epub 2009 Oct 13. J Lipid Res. 2010. PMID: 19826105 Free PMC article.

6

A role for ceramide in driving cancer cell resistance to doxorubicin.

Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, Holleran WM, Giuliano AE, Jazwinski SM, Gouaze-Andersson V, Consoli DP, Cabot MC. Liu YY, et al. FASEB J. 2008 Jul;22(7):2541-51. doi: 10.1096/fj.07-092981. Epub 2008 Feb 1. FASEB J. 2008. PMID: 18245173

7

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.

Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, Mehendale H, Cabot MC, Li YT, Jazwinski SM. Liu YY, et al. Mol Cancer. 2010 Jun 11;9:145. doi: 10.1186/1476-4598-9-145. Mol Cancer. 2010. PMID: 20540746 Free PMC article.

8

Sphingolipids and expression regulation of genes in cancer.

Patwardhan GA, Liu YY. Patwardhan GA, et al. Among authors: liu yy. Prog Lipid Res. 2011 Jan;50(1):104-14. doi: 10.1016/j.plipres.2010.10.003. Epub 2010 Oct 21. Prog Lipid Res. 2011. PMID: 20970453 Free PMC article. Review.

9

Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.

Hosain SB, Khiste SK, Uddin MB, Vorubindi V, Ingram C, Zhang S, Hill RA, Gu X, Liu YY. Hosain SB, et al. Among authors: liu yy. Oncotarget. 2016 Sep 13;7(37):60575-60592. doi: 10.18632/oncotarget.11169. Oncotarget. 2016. PMID: 27517620 Free PMC article.

10

An N⁶-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells.

Uddin MB, Roy KR, Hosain SB, Khiste SK, Hill RA, Jois SD, Zhao Y, Tackett AJ, Liu YY. Uddin MB, et al. Among authors: liu yy. Biochem Pharmacol. 2019 Feb;160:134-145. doi: 10.1016/j.bcp.2018.12.014. Epub 2018 Dec 19. Biochem Pharmacol. 2019. PMID: 30578766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,907 results

Search Page

Filters